SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-0.67%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$198M
AUM Growth
+$198M
(-21%)
Cap. Flow
-$49.5M
Cap. Flow
% of AUM
-24.96%
Top 10 Holdings %
Top 10 Hldgs %
35.51%
Holding
63
New
3
Increased
15
Reduced
20
Closed
18
Top Buys
| 1 |
Alcon
ALC
|
$5.83M |
| 2 |
Grifois
GRFS
|
$3.91M |
| 3 |
Zoetis
ZTS
|
$3.74M |
| 4 |
Cigna
CI
|
$3.04M |
| 5 |
HCA Healthcare
HCA
|
$2.41M |
Top Sells
| 1 |
Pfizer
PFE
|
$6.5M |
| 2 |
Molina Healthcare
MOH
|
$5.73M |
| 3 |
Elanco Animal Health
ELAN
|
$5.07M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
$4.77M |
| 5 |
Smith & Nephew
SNN
|
$4.35M |
Sector Composition
| 1 | Healthcare | 95.79% |
| 2 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Medtronic
MDT
$119B
| $4.35M | 2.19% |
40,000
+10,000
| +33% | +$1.09M |
|
27
Incyte
INCY
$16.5B
| $4.08M | 2.06% |
55,000
+10,000
| +22% | +$742K |
|
28
Tenet Healthcare
THC
$16.3B
| $3.87M | 1.95% |
175,000
+5,000
| +3% | +$111K |
|
|
29
Zoetis
ZTS
$69.3B
| $3.74M | 1.89% |
+30,000
| New | +$3.74M |
|
30
Elevance Health
ELV
$71.8B
| $3.6M | 1.82% |
15,000
-10,000
| -40% | -$2.4M |
|
31
AstraZeneca
AZN
$248B
| $3.57M | 1.8% |
80,000
-20,000
| -20% | -$892K |
|
32
Intuitive Surgical
ISRG
$170B
| $3.3M | 1.67% |
6,118
-1,382
| -18% | -$746K |
|
|
HRC
33
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.16M | 1.59% |
30,000
+15,000
| +100% | +$1.58M |
|
|
34
Cigna
CI
$80.3B
| $3.04M | 1.53% |
+20,000
| New | +$3.04M |
|
35
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.03M | 1.53% |
45,000
+10,000
| +29% | +$674K |
|
36
Centene
CNC
$14.3B
| $1.73M | 0.87% |
40,000
-20,300
| -34% | -$878K |
|
|
SGEN
37
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.71M | 0.86% |
20,000
-15,000
| -43% | -$1.28M |
|
|
BPMC
38
DELISTED
Blueprint Medicines
BPMC
| $1.47M | 0.74% |
20,000
-10,000
| -33% | -$735K |
|
39
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.44M | 0.73% |
40,000
-10,000
| -20% | -$360K |
|
|
SAGE
40
DELISTED
Sage Therapeutics
SAGE
| $1.4M | 0.71% |
10,000
-7,500
| -43% | -$1.05M |
|
41
Teladoc Health
TDOC
$1.37B
| $1.29M | 0.65% |
19,100
-10,900
| -36% | -$738K |
|
42
Sarepta Therapeutics
SRPT
$1.78B
| $1.13M | 0.57% |
15,000
-12,500
| -45% | -$942K |
|
43
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $918K | 0.46% |
45,296
-99,704
| -69% | -$2.02M |
|
44
Agilent Technologies
A
$35.7B
| $766K | 0.39% |
10,000
-35,000
| -78% | -$2.68M |
|
45
Agios Pharmaceuticals
AGIO
$2.19B
| – | – |
-30,000
| Closed | -$1.5M |
|
|
AMED
46
DELISTED
Amedisys
AMED
| – | – |
-20,000
| Closed | -$2.43M |
|
47
Bausch Health
BHC
$2.74B
| – | – |
-140,000
| Closed | -$3.53M |
|
|
BLUE
48
DELISTED
bluebird bio
BLUE
| – | – |
-25,000
| Closed | -$3.18M |
|
|
49
Elanco Animal Health
ELAN
$9.12B
| – | – |
-150,000
| Closed | -$5.07M |
|
50
Exact Sciences
EXAS
$8.98B
| – | – |
-20,000
| Closed | -$2.36M |
|